MGMT immunohistochemistry (IHC) and exclusion of pancreatic NET (PanNET) patients from treatment with temozolomide-based therapy.
Diane Lauren Reidy
No relevant relationships to disclose
Olca Basturk
No relevant relationships to disclose
Anuja Kriplani
No relevant relationships to disclose
Ghassan K. Abou-Alfa
No relevant relationships to disclose
William R. Jarnagin
No relevant relationships to disclose
Peter J. Allen
No relevant relationships to disclose
Leonard Saltz
No relevant relationships to disclose
David S. Klimstra
No relevant relationships to disclose
Liying Zhang
No relevant relationships to disclose